Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Current Assets: 2020-2022

Historic Current Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2022 value amounting to $474.5 million.

  • Cullinan Therapeutics' Current Assets fell 18.10% to $476.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $476.7 million, marking a year-over-year decrease of 18.10%. This contributed to the annual value of $474.5 million for FY2022, which is 59.99% up from last year.
  • According to the latest figures from FY2022, Cullinan Therapeutics' Current Assets is $474.5 million, which was up 59.99% from $296.6 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Current Assets ranged from a high of $474.5 million in FY2022 and a low of $212.3 million during FY2020.
  • Over the past 3 years, Cullinan Therapeutics' median Current Assets value was $296.6 million (recorded in 2021), while the average stood at $327.8 million.
  • Data for Cullinan Therapeutics' Current Assets shows a peak YoY spiked of 59.99% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Cullinan Therapeutics' Current Assets stood at $212.3 million in 2020, then surged by 39.71% to $296.6 million in 2021, then spiked by 59.99% to $474.5 million in 2022.